| 中文别名 |
左羟丙哌嗪;(S)-3-(4-苯基-1-哌嗪基)-1,2-丙二醇;2,3,4,7,8--五氯二苯并对呋喃;Levodropropizine(S-羟丙哌嗪);左羟丙哌嗪 EP标准品;左羟丙哌嗪 标准品;S(-)-3-(4-苯基-1-哌嗪)-1,2-丙二醇;醋酸甲羟孕酮杂质F;(S)-(-)-羟丙哌嗪;(S)-3-(4-苯基哌嗪-1-基)丙烷-1,2-二醇 |
| 英文别名 |
(S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol;Levodropropizine;(2S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol;Danka;l-Dropropizine;Levotuss;LVDP;Rapitux;(S)-(-)-Dropropizine;(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol;(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol;Levdropropizine;(-)-Dropropizine;Levodropropizina;Levodropropizinum;Levodropropizinum [INN-Latin];Levodropropizina [INN-Spanish];Levodropropizine [INN];DF 526;3O31P6T4G3;S(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol;(-)-(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol;1,2-Propanediol, 3-(4-phenyl-1-pi;Levopront;BRD-K83551379-001-02-6;SCHEMBL29043;CS-5212;Levodropropizine (INN);DTXSID8023210;DB12472;CHEMBL1288810;NS00096429;L0339;CAS-17692-31-8;AKOS015889397;CCG-266840;NCGC00016730-01;Q408131;Salvituss;AO-022/43512153;Levopront (TN);99291-25-5;Levodropropizine impurity A;1,2-Propanediol, 3-(4-phenyl-1-piperazinyl)-, (2S)-;DROPROPIZINE S-FORM [MI];Levodropropizine; (2S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol;Dropropizine S-form;Q-100916;AS-12822;Dropropizine, (s)-;F15098;PTVWPYVOOKLBCG-ZDUSSCGKSA-N;Z301111588;(2S)-3-(4-PHENYL-1-PIPERAZINYL)-1,2-PROPANEDIOL;LEVODROPROPIZINE [EP MONOGRAPH];L-dropropizine;Levodropropizine [INN:BAN];s4131;HY-B1895;D08119;HMS3885B07;1,2-PROPANEDIOL, 3-(4-PHENYL-1-PIPERAZINYL)-, (S)-;A845991;LEVODROPROPIZINE [WHO-DD];MFCD00866852;AC-8088;UNII-3O31P6T4G3;AC-2084;dipropizine, (S)-isomer;LEVODROPROPIZINE [MART.];NCGC00018230-01;S-(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol;BCP9000850;1,2-Propanediol, 3-(4-phenylpiperazin-1-yl)-, S(-)-;EN300-1718684;CHEBI:82722;NCGC00018230-06;BCP0726000048;DF-526;(s)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol |
微信公众号
